Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug-drug interaction study of SMP-508 and sitagliptin
jRCT2080221771Phase 1
- Sponsor
- Sumitomo Pharma
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of repaglinide in type 2 diabetes mellitus (T2DM), sponsored by Sumitomo Pharma. Primary endpoint: Primary pharmacokinetic interaction endpoints.
02
Drugs
repaglinide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080221771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221771.